Opendata, web and dolomites

AutoPilot-Dx SIGNED

Fast tracking market adoption of a novel immune-based diagnostic for improving antibiotic stewardship: automation, piloting and health economics

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 AutoPilot-Dx project word cloud

Explore the words cloud of the AutoPilot-Dx project. It provides you a very rough idea of what is the project "AutoPilot-Dx" about.

differentiate    strategy    performance    rapid    hands    stewardship    roll    fever    sustainable    cross    business    overcomes    8b    emergency    children    ce    reduce    disease    close    limitations    bacterial    platform    transition    received    fws    diagnostic    fight    25    infections    diagnosis    industry    doctor    adoption    immunoxpert    patient    health    dx    positioned    tract    fast    automated    care    vitro    innovation    road    visits    utility    hospitalized    free    ivd    time    infectious    accounts    goals    economic    hospitals    benefit    ed    uniquely    economics    20    viral    societal    personalized    body    breakthrough    strategies    antibiotic    kols    diagnostics    560m    effort    respiratory    regulatory    laboratory    reimbursement    memed    aligned    autopilot    outperforming    resistance    50    leverages    standard    rtis    rti    map    threat    hospitalization    assay    clearance    tecan    1200    trade    pediatric    points    line    ftipilot    outcome    identifiable    patients    pilot    clinical    market    track    first    global    perform    accurately    source    entry    immune   

Project "AutoPilot-Dx" data sheet

The following table provides information about the project.

Coordinator
MEMED DIAGNOSTICS LTD 

Organization address
address: NAHUM HETH STREET 5
city: TIRAT CARMEL
postcode: 39120
website: www.me-med.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website https://www.autopilotdx.org/
 Total cost 2˙923˙250 €
 EC max contribution 2˙293˙900 € (78%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2. (PRIORITY 'Industrial leadership')
 Code Call H2020-FTIPilot-2015-1
 Funding Scheme IA
 Starting year 2016
 Duration (year-month-day) from 2016-09-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MEMED DIAGNOSTICS LTD IL (TIRAT CARMEL) coordinator 655˙025.00
2    QUANTIFY RESEARCH AB SE (STOCKHOLM) participant 437˙500.00
3    RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG DE (HEIDELBERG) participant 415˙625.00
4    UNIVERSITA DEGLI STUDI DI PERUGIA IT (PERUGIA) participant 388˙687.00
5    TECAN DEUTSCHLAND GMBH DE (CRAILSHEIM) participant 370˙125.00
6    UNIVERSITA DEGLI STUDI DI MILANO IT (MILANO) participant 26˙937.00

Map

 Project objective

MeMed has completed development of ImmunoXpert™, an in vitro diagnostic test that leverages the body’s immune system to accurately differentiate between bacterial and viral infections. A breakthrough in infectious disease diagnosis, ImmunoXpert™ overcomes limitations of traditional diagnostics, outperforming standard of care. ImmunoXpert™ recently received regulatory European clearance (CE-IVD) and represents a close-to-market innovation. Market entry points include emergency department and hospitalized pediatric patients with respiratory tract infections (RTI) and fever without source (FWS), for which ImmunoXpert™ is uniquely positioned to improve patient management and health economics. In children, RTIs account for 50% of doctor visits and hospitalization. Fever accounts for 10-25% of pediatric ED visits, with as many as 20% without identifiable source. The global market for ImmunoXpert™ diagnosis of pediatric RTI/FWS is €2.8B (EU is €560M). To fast track market adoption across Europe we propose: •To transition ImmunoXpert™ from a hands-on laboratory assay to Tecan’s hands-free, rapid automated laboratory platform to increase clinical utility and economic benefit •To roll-out ImmunoXpert™ to EU pilot hospitals with the goal of managing 1200 pediatric patients to evaluate performance and clinical utility in real working conditions •To perform health economics analysis and establish reimbursement strategy

AutoPilot-Dx is a cross sector effort (industry, KOLs, outcome researchers) highly aligned with H2020-FTIPilot’s goals and Societal Challenges: it will reduce ImmunoXpert™’s time to market and provide a road-map for sustainable market uptake; a H2020 first-time applicant is involved; the project will enable MeMed and Tecan to scale-up in line with their business strategies; the immune-based diagnostics will improve antibiotic stewardship, providing better, personalized, care for children with RTI/FWS and help fight antibiotic resistance – a global health threat

 Deliverables

List of deliverables.
Peer-reviewed publication describing the \'InSight\' study Websites, patent fillings, videos etc. 2020-02-12 11:53:54
HE peer-reviewed publication Websites, patent fillings, videos etc. 2020-02-12 11:53:56
A dedicated website for promoting the AutoPilot-Dx consortium Websites, patent fillings, videos etc. 2019-11-26 12:14:43
Presenting \'InSight\' study results in an infectious disease Websites, patent fillings, videos etc. 2019-11-26 12:14:43

Take a look to the deliverables list in detail:  detailed list of AutoPilot-Dx deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "AUTOPILOT-DX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "AUTOPILOT-DX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.)

Innovation Principle (2019)

Developing an Innovation-Friendly Legislative Culture – the Innovation Principle at Work

Read More  

PULSe (2017)

Pervasive Ubiquitous Lightwave SEnsor

Read More  

MedEye (2017)

Accelerated market launch of MedEye, a plug-and-play medication safety solution

Read More